Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. Cannabis Growers Post Positive Profits, Earnings; Canadians Still Struggle

By Investing.com (Brenda O'Farrell/Investing.com)Stock MarketsAug 17, 2021 04:38
ca.investing.com/analysis/us-cannabis-growers-post-positive-profits-earnings-canadians-still-struggle-200485212
U.S. Cannabis Growers Post Positive Profits, Earnings; Canadians Still Struggle
By Investing.com (Brenda O'Farrell/Investing.com)   |  Aug 17, 2021 04:38
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Several US-based cannabis companies reported earnings last week. Overall, the figures paint a distinctive picture that put a focus on profitability.

The portrait also provides a study in contrast—US cannabis companies are posting profits. It is not quite the same story for Canadian marijuana growers, which are still attempting to find their way to this lofty destination.

Trulieve Offers Strong Showing

Among the recent earnings reports, Trulieve (OTC:TCNNF) (CSE:TRUL) put in a strong showing. The Florida-based cannabis grower’s second quarter report posted a gross profit of $144.5 million and an adjusted net income of $40.9 million, which was just over analysts’ estimates of $40.2 million.

Trulieve Daily
Trulieve Daily

The company also announced it has completed its deal to acquire Harvest Health & Recreation (OTC:HRVSF) (CSE:HARV), one of the largest acquisition in the US cannabis sector. Originally announced in May, the $2.1-billion all-stock deal, which was given final approved on Aug. 11, merged two multi-state operators and provides Trulieve with access to the market in Arizona, expanding its reach.

“Harvest will increase our addressable market by 53%, so it really is a transaction that we believe will set us up for cannabis 2.0 in this country, as we think how our hub model will evolve.”

Shares of Trulieve closed yesterday at $28.01. The stock has gained just over 19.5% in the last year.

Curaleaf Sees Revenue Gains

Curaleaf Holdings (OTC:CURLF) (CSE:CURA) also posted impressive results, including a 166% increase in revenues compared with the same quarter the previous year.

Curaleaf Daily
Curaleaf Daily

The quarter that ended June 30 saw revenues hit $312 million.

The reporting period also saw the Massachusetts-based company close its deal to acquire EMMAC Life Sciences, the largest vertically-integrated cannabis company in Europe. The $286-million share and cash deal gives Curaleaf access to the markets in the UK, Germany, Italy, Spain and Portugal.

Shares of Curaleaf closed yesterday at $11.54, down 4.3% on the day. In the last year, however, the stock has increased just over 33.5%.

Green Thumb Beat Expectations

Green Thumb Industries (OTC:GTBIF) (CSE:GTII) also topped expectations with its earnings report last week. The Chicago-based company saw revenues increase 85.4% year over year, hitting $221.9 million for the quarter.

Green Thumb Daily
Green Thumb Daily

“On a year-over-year basis, we grew revenue by 85% to $222 million; more than doubled adjusted EBITDA to $79 million and continued to deliver positive cash flow,” said founder and Chief Executive Officer Ben Kovler.

Gross profit for the second quarter 2021 was $122.9 million or 55.4% of revenue compared to $63.7 million or 53.2% of revenue year-over-year.

The company also reported on its acquisition of Liberty Compassion, a Massachusetts-based medical cannabis grower and retailer, expanding Green Thumbs operations in the state.

Shares of Green Thumb closed yesterday at $30.89, down 2.4% on the day. The stock has seen spectacular gains in the last year, increasing about 97.7%.

And rounding out the upbeat earnings showing was Chicago-based Cresco Labs (OTC:CRLBF) (CSE:CL), which reported last Friday.

Its biggest headline metric was net income, which came in at $2.7 million, well ahead of analyst estimates of $1.5 million.

Cresco also reported net wholesale revenue of $108.7 million, a 97.9% increase over the same quarter in the previous year, and retail revenue of $101.3 million, a 157.6% year-over-year increase.

“Q2 was a strong quarter of head-down execution at Cresco Labs and once again we are hitting our stride as we enter the next phase of growth,” said co-founder and CEO Charles Bachtell in a statement.

Shares of Cresco Labs closed yesterday at $10.10, down about 3% on the day. In the last year, the stock has increased almost 44 %.

U.S. Cannabis Growers Post Positive Profits, Earnings; Canadians Still Struggle
 

Related Articles

U.S. Cannabis Growers Post Positive Profits, Earnings; Canadians Still Struggle

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email